Dual Listing Explained

Most patients hear about multi listing after they are evaluated at a transplant center, or even after they are listed. Often it is mentioned in passing, in a way that does not fully register at the time. Someone may have raised it during an early appointment. It may have been one bullet in a handout.

Most often, it shows up in the welcome folder, the packet of paperwork that comes when you begin the listing process, the one with consent forms to sign and information sheets to return. Somewhere in that folder is a brochure that says you are allowed to be listed at more than one transplant center. It is a real, accurate, useful document. UNOS, which produces it, has done its part. That brochure is important. This article is here to tell you why.

What does it mean to be dual listed?

Dual listing means being on the waiting list at more than one transplant center at the same time. Nothing about your first listing changes. You stay on that list, with the same team and the same standing you have today. A second center simply adds you to its list as well.

From that point on, both centers can receive an organ offer for you. If an offer comes, the center that received it contacts you, and you and that team decide together whether to accept it. You are never asked to choose between your centers ahead of time, and saying yes to one is not a rejection of the other. Both are working toward the same thing, which is getting you a liver.

If the idea feels disloyal, or like you would be taking something from other patients who are waiting, you are not alone in feeling that. Many patients hesitate right here. It may help to know that dual listing does not move you above anyone. Your MELD score sets your place at every center, the same way for every patient. What a second listing changes is which donor offers can reach you, not whose place you take.

When the count is more than two centers, the same practice is called multiple listing or multi listing. The transplant community uses both terms. They mean the same thing.

Why is dual listing important?

Liver disease does not wait. The choices you make about where to be evaluated and where to be listed shape how the rest of your transplant journey unfolds. Most patients do not know those choices are theirs to make. By the time they could act on them, others have already acted for them.

Part of the reason is training. Most of us have spent our whole lives moving through medicine by referral. Your primary doctor refers you to a specialist. The specialist refers you to a hospital. Insurance reinforces it at every step, and after enough years, waiting to be sent somewhere stops feeling like a habit and starts feeling like the rule. So when a transplant center becomes the center of your care, it is natural to assume that any move to another center has to start with them.

It does not. In liver transplant, most centers take self-referrals, which means you, or the person who cares for you, can call a program directly, ask what its evaluation involves, and begin the process without anyone sending you there. No permission slip. No gatekeeper. Most patients have never been told this, and it changes what is possible. The patients who wait for the system to route them go where the system routes them. The patients who know they can pick up the phone have choices.

Dual listing is one of the few decisions a patient can make to change the path, and self-referral is how the decision becomes real. Time is the thing every patient on the waiting list is short on, and dual listing works by widening the set of donors who can reach you. It is not the right step for every patient, but for many, it is worth understanding well before you have to decide.

How can dual listing help me?

Being listed at a second center can change two things that matter.

First, it puts you in front of more donor organs. Liver allocation in the United States is based on the distance between a donor hospital and a transplant center. A patient listed at one center is considered for offers from donors near that center. A patient listed at two centers, in two different areas, is considered for offers from donors near both. Two locations, two pools of donors.

Second, it can change the score you need to receive a transplant. Each transplant program has a number called median MELD at transplant. It is the middle MELD score among patients who were actually transplanted at that program in the past year. It varies significantly across the country. A patient with a MELD of 25 might receive a transplant quickly at one center and never reach the threshold at another. The same patient. The same score. Two different outcomes, depending on where they are listed.

How do the lists actually work?

Most patients are told there is one waiting list, run by UNOS. That is true at one level. UNOS maintains a single national registry. But the way organs are actually offered is not one big list. It is many lists at once, sorted by distance from the donor hospital.

When a deceased donor liver becomes available, the system draws three circles around the donor hospital: 150, 250, and 500 nautical miles. It looks first at the most urgent patients in the closest circle, then works outward by medical urgency and distance.

You may hear hospitals or other patients talk about OPTN “regions.” Before February 2020, regions were the allocation unit. They are not anymore. Today, distance from the donor hospital is what matters.

Technology is extending that distance. In September 2025, the FDA cleared the OrganOx perfusion device for use during chartered flights. Centers with this capability can accept donor livers from farther away than before, and a center you once ruled out as too far may now be within reach, for the organ and for you.

Who tends to benefit most?

Dual listing is not equally useful for every patient. Some situations make it more likely to change an outcome:

• Patients whose MELD score sits below their current center’s median MELD at transplant, especially when the score has been stable for months and is not climbing fast enough to reach it.

• Patients whose MELD does not show how sick they actually are. Complications like ascites, encephalopathy, repeated bleeding, or an enlarged spleen can make life unlivable while the score barely moves. A center whose typical patient transplants at a lower score can change the math for exactly this patient.

• Patients with liver cancer (hepatocellular carcinoma) whose MELD does not reflect the urgency of their disease, particularly when the wait at their current center exceeds the safe window for their tumor.

• Patients whose current center does not accept certain kinds of organs, such as DCD livers or organs preserved on a machine perfusion device, when a second center in a different area does.

• Patients with a potential living donor who can be evaluated at a center with more living-donor experience, while staying on the deceased-donor list at the original center.

• Patients who already have a foothold in a second geography, through a recent move, family in another city, or the real ability to travel. For them, the second donor pool is not a plan to build. It is already there.

If none of these describe your situation, dual listing may still be worth understanding, but it may not change the outcome enough to justify the cost. If one or more do describe your situation, this article exists to make sure you know about it.

Is it allowed?

Yes. It has been allowed by federal policy since 1987. The transplant center where you are currently listed is required to tell you it is allowed. That is also federal policy.

Two policies govern this.

WHAT THE POLICY SAYS

OPTN Policy 3.2: Notifying Patients on their Options

Every transplant program must tell patients in writing that they are allowed to be registered at more than one transplant program.

WHAT THE POLICY SAYS

OPTN Policy 3.4: Multiple Transplant Program Registrations

Patients may be registered at more than one transplant program at the same time. Each program decides on its own whether to add a patient who is also listed somewhere else to its waiting list.

What happens to the time you have already waited?

Waiting time works differently than people expect. The time you have already waited at your first center does not double when you are listed at a second one. It stays where it is, or it can be moved, or it can be split between centers. The official term is “primary waiting time.”

WHAT THE POLICY SAYS

OPTN Policy 3.6.C: Waiting Time Transfer

Your longest accumulated waiting time at any one program is your primary waiting time. It can be transferred between programs or split between them. It cannot be added across them.

What do I need to do in order to dual list, and what tools can help?

A second listing is real work, but less of it falls on you than most patients fear. The first answer is simple: make the phone call, start the process, keep moving through it.

The second center’s coordinators do most of the heavy lifting. They request your records from your first center, review what transfers, and order only what they still need. At many centers, though not all, much of the remaining testing can be done near your home, with results sent to the new program. One of the patients we have helped completed additional testing in California while listing at a center in Arizona. Every program handles this differently, but they walk you through it. That is the coordinator’s job.

Plan on being on site at least once, and more likely twice, before you are listed: typically a first visit to meet the team and begin the evaluation, then a return trip about a month later for a follow-up meeting and any remaining tests. You will need time off work for those trips, for yourself and for whoever goes with you, and you may need lodging. It is real effort. It is also organized effort, with a coordinator whose job is to move you through it. Other patients have walked this road before you.

This is where self-referral becomes practical. The evaluation starts with one phone call that you are allowed to make yourself.

Four free tools can help with the parts of this work that an exhausted patient cannot reasonably be expected to do from scratch.

The Compare Centers Tool. A map of every U.S. liver transplant center, with the public data your team is already using. Filter by your MELD score, your blood type, your geography. See each center’s median MELD at transplant to understand where the math at one center differs from the math at another. Filter for centers that use perfusion technology. The tool does not rank centers and does not recommend any specific one. It shows you the same public data your team uses, made readable for you. nationalfriends.org/your_options/

Dual Listing: The Guide. A free plain-language guide that explains what dual listing is, why it matters, and how to do it, with the graphics and numbers behind everything in this article. Download it free at nationalfriends.org/journey/

The Dual Listing Workbook. The guide’s fillable companion. A MELD tracker, a full page for every program you are weighing with travel and insurance built in, a timeline for your months on the list, and the questions to bring to your team and to any new program you call. Download it free at nationalfriends.org/journey/

The National Friends Support Line. If you have questions and you would rather talk to a person, our support line is staffed by people who have been through this. They are not your transplant team and they do not give medical advice. They help you make sense of what you are seeing and where to go next. Call 1-866-521-6319 or visit nationalfriends.org/support/

How do I talk to my team about dual listing?

Most transplant teams respond well to patients asking about their options. They know the policy. They know dual listing is permitted. They expect the question from informed patients, and many appreciate it. Asking is not a betrayal of your team. It is a question about a recognized practice the policy already requires them to disclose.

If the conversation goes well, you have learned something good about your team. If it goes poorly, that is information too. Not a verdict on you, but a signal worth noticing. Either way, you walked in informed.

SOURCES

Organ Procurement and Transplantation Network. “Policy 3.4: Multiple Transplant Program Registrations.” OPTN Policies. Accessed May 2026. https://optn.transplant.hrsa.gov/policies-bylaws/policies/.

Organ Procurement and Transplantation Network. “Policy 3.2: Notifying Patients on their Options.” OPTN Policies. Accessed May 2026. https://optn.transplant.hrsa.gov/policies-bylaws/policies/.

Organ Procurement and Transplantation Network. “Policy 3.6.C: Waiting Time Transfer.” OPTN Policies. Accessed May 2026. https://optn.transplant.hrsa.gov/policies-bylaws/policies/.

Organ Procurement and Transplantation Network. “Frequently Asked Questions about Multiple Listing and Waiting Time Transfer.” OPTN Patient Resources. Accessed May 2026. https://optn.transplant.hrsa.gov/patients/about-transplantation/multiple-listing/.

Health Resources and Services Administration. “Multiple Listing.” HRSA OPTN Patient Resources. Accessed May 2026. https://www.hrsa.gov/optn/patients/organ-transplants/multiple-listing.

Organ Procurement and Transplantation Network. “Ethical Evaluation of Multiple Listing.” OPTN Ethics Committee White Paper. Accessed May 2026. https://optn.transplant.hrsa.gov/policies-bylaws/public-comment/ethical-evaluation-of-multiple-listing/.

Health Resources and Services Administration. “National Organ Transplant Act of 1984, Public Law 98-507.” HRSA. Accessed May 2026. https://www.hrsa.gov/get-organ-transplant/national-organ-transplant-act.Health Resources and Services Administration. “National Organ Transplant Act of 1984, Public Law 98-507.” HRSA. Accessed May 2026. https://www.hrsa.gov/get-organ-transplant/national-organ-transplant-act.